Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
John K Bakewell is Director at Xtant Medical Holdings. OQRO lists 4 transactions filed with the SEC under this name, the latest on Aug 18, 2026, each linked to the official Form 4.
Director
Disclosures on record
4
Companies involved
2
John K Bakewell bought shares on the open market in 2024, and has not bought since 2024 across 2 companies. Sales in 1 of the 4 years since 2023.
John K Bakewell reported 1 open-market purchase and 1 sale since 2023; purchases in 2024.
| Year | Bought | Sold |
|---|---|---|
| 2024 | $594K1×1 trade | — |
| 2023 | — | $39K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Xtant Medical HoldingsXTNT
3 disclosures · Nov 2025 – Aug 2026
Aug 15, 2026216Kdisclosed Aug 18
DetailsOfficial recordNov 15, 2025158Kdisclosed Nov 18
DetailsOfficial recordNov 15, 2025158Kdisclosed Nov 18
DetailsOfficial recordMay 19, 202630Kdisclosed May 20
DetailsOfficial recordAs of the latest filing on , John K Bakewell reported holding 204,056 shares of Treace Medical Concepts (TMCI), worth about $906K at the last close of $4 (Nov 17, 2026). Holdings are also on file at Xtant Medical Holdings (XTNT); together they are worth about $1.14M.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Treace Medical Concepts TMCI | 204,056 | 204K direct | $4 | $906K | May 19, 2026 |
| Xtant Medical Holdings XTNT | 1,129,633 | 1.13M direct | $0 | $232K | Aug 15, 2026 |
Is this John K Bakewell’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
John K Bakewell reported 1 open-market purchase and 0 sales here, 2024.
John K Bakewell reported 0 open-market purchases and 1 sale here, 2023.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated May 19, 2026, John K Bakewell reported holding 204,056 shares of Treace Medical Concepts (TMCI). At the last close of $4 on Nov 17, 2026, that is about $906K. This is the stake disclosed in filings, not a net worth.
John K Bakewell bought shares on the open market in 2024, and has not bought since 2024 across 2 companies. Sales in 1 of the 4 years since 2023.
In SEC filings since 2023: the latest open-market purchase is from 2024; the latest open-market sale is from 2023.
2 companies: Treace Medical Concepts (TMCI, 2024), Neuronetics (STIM, 2023).